| Abstrakt: |
SOUTH SAN FRANCISCO, Calif., Sept. 7, 2022 /PRNewswire/ -- Molecular Stethoscope, a leading precision medicine company pioneering the next-generation cell-free mRNA (cf-mRNA) liquid biopsy, announced publication of the study entitled "Survey of extracellular communication of systemic and organ-specific inflammatory responses through cell free messenger RNA profiling in mice" in eBiomedicine, part of Lancet Discovery Science, a leading biomedical journal, that bridges the translational gap between basic and clinical research. The understanding of inflammatory and immune responses is incomplete; the Molecular Stethoscope team was able to dissect systemic and solid organ contributors and effectively monitor progressive inflammation and the efficacy of a pharmacotherapy interventional approach. [ABSTRACT FROM PUBLISHER] |
